Dopaminergic dysfunction may not indicate Lewy body dementia

05/6/2013 | MolecularImaging.net

A Journal of Nuclear Medicine study that used SPECT imaging with I-123 PE21 found that binding of the tracer to the dopamine transporter system did not show a clear link with signs of Lewy body dementia. "Our results suggest that the general level of cognitive impairment in DLB patients is not influenced by striatal dopaminergic dysfunction," researchers said. However, they noted more research is needed to substantiate their findings.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD